| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse events to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis due to elevated drug exposure?: A case series
|
Baromeo, Syendon B C
|
|
|
24 |
3 |
p. 516-520
|
artikel
|
| 2 |
Assessing 129Xe multi-breath washout MRI response to elexacaftor/tezacaftor/ivacaftor intervention in pediatric CF
|
Alam, Faiyza
|
|
|
24 |
3 |
p. 593-600
|
artikel
|
| 3 |
Breastfeeding, growth, and lung disease in the first 3 years of life in children with cystic fibrosis
|
Lai, HuiChuan J.
|
|
|
24 |
3 |
p. 507-515
|
artikel
|
| 4 |
CFTR modulators and pregnancy outcomes: Early findings from a nationwide cohort study
|
Chouchana, Laurent
|
|
|
24 |
3 |
p. 469-475
|
artikel
|
| 5 |
CFTR modulator therapy via carrier mother to treat meconium ileus in a F508del homozygous fetus: Insights from an unsuccessful case
|
Destoop, M.
|
|
|
24 |
3 |
p. 476-478
|
artikel
|
| 6 |
Clinical features associated with self-reported food insecurity in people with cystic fibrosis
|
Boas, Heather
|
|
|
24 |
3 |
p. 621-625
|
artikel
|
| 7 |
Contents
|
|
|
|
24 |
3 |
p. i-iii
|
artikel
|
| 8 |
Contraceptive use and pregnancy in cystic fibrosis: Survey findings from 10 cystic fibrosis centers
|
Godfrey, Emily M.
|
|
|
24 |
3 |
p. 491-497
|
artikel
|
| 9 |
Does using the Lung Clearance Index (LCI) inform clinical decisions in children with cystic fibrosis?
|
Perrem, Lucy
|
|
|
24 |
3 |
p. 601-605
|
artikel
|
| 10 |
Dry eye disease and morphological changes in the anterior chamber in people with cystic fibrosis
|
Gutiérrez, Patricia
|
|
|
24 |
3 |
p. 626-633
|
artikel
|
| 11 |
Effect of elexacaftor-tezacaftor-ivacaftor on liver transient elastography, fibrosis indices and blood tests in children with cystic fibrosis
|
Terlizzi, Vito
|
|
|
24 |
3 |
p. 574-580
|
artikel
|
| 12 |
Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplant
|
Guimbellot, JS
|
|
|
24 |
3 |
p. 534-541
|
artikel
|
| 13 |
Evaluation of clinical practice guidelines on treatment of cystic fibrosis: A systematic review
|
Huang, Yuting
|
|
|
24 |
3 |
p. 446-456
|
artikel
|
| 14 |
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers
|
Conti, Jessica
|
|
|
24 |
3 |
p. 552-561
|
artikel
|
| 15 |
First real-world study of fetal therapy with CFTR modulators in cystic fibrosis: Report from the MODUL-CF study
|
Bonnel, Anne-Sophie
|
|
|
24 |
3 |
p. 457-465
|
artikel
|
| 16 |
Immunogenic adverse events to CFTR modulators – An international survey
|
Urbantat, Ruth M.
|
|
|
24 |
3 |
p. 521-525
|
artikel
|
| 17 |
Intimacy and sexual life of females with cystic fibrosis
|
Simonnet Bisson, Françoise
|
|
|
24 |
3 |
p. 479-483
|
artikel
|
| 18 |
Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on the oropharyngeal metagenome in adolescents with cystic fibrosis
|
Steinberg, Ruth
|
|
|
24 |
3 |
p. 562-570
|
artikel
|
| 19 |
Lung-kidney axis in cystic fibrosis: Early urinary markers of kidney injury correlate with neutrophil activation and worse lung function
|
Rosner, Grace M.
|
|
|
24 |
3 |
p. 613-620
|
artikel
|
| 20 |
Male sexual and reproductive health in cystic fibrosis: A concept mapping study
|
Prangley, Kelly A.
|
|
|
24 |
3 |
p. 484-490
|
artikel
|
| 21 |
Measurement of treatment burden in cystic fibrosis: A systematic review
|
Altabee, Rana
|
|
|
24 |
3 |
p. 434-445
|
artikel
|
| 22 |
Mental health, behaviour and sleep quality in children 6–11 years before and after elexacaftor/tezacaftor/ivacaftor initiation
|
Douglas, Tonia
|
|
|
24 |
3 |
p. 571-573
|
artikel
|
| 23 |
Monitoring ETI effects over 1.7 years in an infant treated in utero, via breast milk and granules by repeated faecal elastase measurements
|
Appelt, Dorothea
|
|
|
24 |
3 |
p. 504-506
|
artikel
|
| 24 |
News article
|
|
|
|
24 |
3 |
p. 431-433
|
artikel
|
| 25 |
Non-invasive evaluation of steatosis and fibrosis in the liver in adults patients living with cystic fibrosis
|
Piñar-Gutiérrez, Ana
|
|
|
24 |
3 |
p. 581-589
|
artikel
|
| 26 |
Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis
|
Metcalf, Angela
|
|
|
24 |
3 |
p. 466-468
|
artikel
|
| 27 |
Personalized therapy with CFTR modulators: Response of p.Ile148Asn variant
|
Rodrigues, Cláudia S
|
|
|
24 |
3 |
p. 542-547
|
artikel
|
| 28 |
Real-world pharmacokinetics of elexacaftor-tezacaftor-ivacaftor in children with cystic fibrosis: a prospective observational study
|
Vonk, Steffie E.M.
|
|
|
24 |
3 |
p. 526-533
|
artikel
|
| 29 |
Resolution of portal hypertension in a patient with cystic fibrosis after treatment with CFTR modulator: A case report
|
Loon, Erica
|
|
|
24 |
3 |
p. 590-592
|
artikel
|
| 30 |
Short-term modification of breathprint by Elexacaftor/Tezacaftor/Ivacaftor in a paediatric cohort
|
Bardin, Emmanuelle
|
|
|
24 |
3 |
p. 606-612
|
artikel
|
| 31 |
The impact of pregnancy on mortality and lung function in cystic fibrosis patients
|
Mohabir, Paul K.
|
|
|
24 |
3 |
p. 498-503
|
artikel
|
| 32 |
Treatment effects of elexacaftor/tezacaftor/ivacaftor on people with cystic fibrosis heterozygous for 3849+10kbC->T and a class I variant
|
Heching, Moshe
|
|
|
24 |
3 |
p. 548-551
|
artikel
|
Tijdschrift beschrijving